Clincosm LogoSign in Get a demo

vegf

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

Not yet recruiting
  • Lung Adenocarcinoma
  • +3 more
  • Serplulimab and Bevacizumab injection
  • (no location specified)
Dec 21, 2022

Anti-VEGF Targeted Drugs on Patients' Blood Pressure and

Recruiting
  • Cardiac Toxicity
  • +2 more
  • Peking, Beijing, China
    Peking University Third Hospital
Jul 4, 2021

Development of Renal Carcinoma in Renal Transplant Patients

Unknown status
  • Polymorphism
  • +3 more
  • To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 10, 2017

Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment Trial in Worldwide (TKI258)

Completed
Has Results
  • Solid Tumors and Advanced Endometrial Cancer
  • +3 more
  • Mobile, Alabama
  • +44 more
May 2, 2015

Pterygium, Bevacizumab, VEGF Trial in Pathumwan (bevacizumab eye drop 0.05%, normal saline 0.9%)

Completed
  • Pterygium
  • +3 more
  • bevacizumab eye drop 0.05%
  • normal saline 0.9%
  • Pathumwan, Bangkok, Thailand
    Faculty of medicine, Chulalongkorn university
Apr 6, 2013

Embryonic Development, Pregnancy, VEGF Trial in Brussels (10000 IU urinary HCG, 250 mcg recombinant HCG)

Unknown status
  • Embryonic Development
  • +2 more
  • 10000 IU urinary HCG
  • 250 mcg recombinant HCG
  • Brussels, Jette, Belgium
    Centre for Reproductive Medicine, UZ Brussel
Dec 23, 2009